These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 7804695)
21. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. Witherspoon RP; Fisher LD; Schoch G; Martin P; Sullivan KM; Sanders J; Deeg HJ; Doney K; Thomas D; Storb R N Engl J Med; 1989 Sep; 321(12):784-9. PubMed ID: 2671734 [TBL] [Abstract][Full Text] [Related]
22. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies]. Michallet M; Dhedin N; Michallet AS Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365 [TBL] [Abstract][Full Text] [Related]
23. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen. Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960 [TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases. Hauke RJ; Greiner TC; Smir BN; Vose JM; Tarantolo SR; Bashir RM; Bierman PJ Bone Marrow Transplant; 1998 Jun; 21(12):1271-4. PubMed ID: 9674863 [TBL] [Abstract][Full Text] [Related]
25. Fatal post-transplant lymphoproliferative disorder following allogeneic bone marrow transplantation for aplastic anemia. Rudzki Z; Werda L; Piatkowska-Jakubas B; Mensah P; Zazula M; Białas M; Skotnicki AB; Stachura J Pol J Pathol; 2002; 53(1):35-40. PubMed ID: 12014224 [TBL] [Abstract][Full Text] [Related]
26. High fatality rate of Epstein-Barr virus-associated lymphoproliferative disorder occurring after bone marrow transplantation with rabbit antithymocyte globulin conditioning regimens. Peres E; Savasan S; Klein J; Abidi M; Dansey R; Abella E J Clin Microbiol; 2005 Jul; 43(7):3540-3. PubMed ID: 16000501 [TBL] [Abstract][Full Text] [Related]
27. Special Education: Aplastic Anemia. Teramura M; Mizoguchi H Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986 [TBL] [Abstract][Full Text] [Related]
28. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia. Lawler M; Locasciulli A; Longoni D; Schiro R; McCann SR Bone Marrow Transplant; 2002 Mar; 29(5):453-6. PubMed ID: 11919737 [TBL] [Abstract][Full Text] [Related]
29. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft. Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494 [TBL] [Abstract][Full Text] [Related]
30. Bone marrow transplantation in Taiwan: low incidence of acute GVHD in patients with hematologic malignancies and severe aplastic anemia. Chen PM; Tzeng CH; Fan FS; Hsieh RK; Wei CH Bone Marrow Transplant; 1994 Jun; 13(6):709-11. PubMed ID: 7920299 [TBL] [Abstract][Full Text] [Related]
31. Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation. Lynch BA; Vasef MA; Comito M; Gilman AL; Lee N; Ritchie J; Rumelhart S; Holida M; Goldman F Bone Marrow Transplant; 2003 Sep; 32(5):527-33. PubMed ID: 12942101 [TBL] [Abstract][Full Text] [Related]
32. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation. Sobecks RM; Le Beau MM; Anastasi J; Williams SF Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956 [TBL] [Abstract][Full Text] [Related]
33. Bone marrow 'boosts' following T cell-depleted haploidentical bone marrow transplantation. Kline RM; Stiehm ER; Cowan MJ Bone Marrow Transplant; 1996 Apr; 17(4):543-8. PubMed ID: 8722352 [TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus-negative high grade B cell lymphoma of donor origin developing 19 months after unrelated allogeneic bone marrow transplantation. Gomyo H; Murayama T; Kizaki T; Mizuno I; Kitaori K; Sao H; Tobinai K; Koizumi K; Imoto S Bone Marrow Transplant; 2000 Sep; 26(5):577-9. PubMed ID: 11019851 [TBL] [Abstract][Full Text] [Related]
35. Remission of a lymphoproliferative disorder occurring after second BMT from an unrelated donor in a 5-year-old boy with severe aplastic anemia. Bader P; Klingebiel T; Klingel K; Föll J; Beck J; Handgretinger R; Ehninger G; Deeg HJ; Niethammer D Bone Marrow Transplant; 1995 Sep; 16(3):479-81. PubMed ID: 8535324 [TBL] [Abstract][Full Text] [Related]